Skip to content

LDMO

Active
Private limited companyfounded 2025active for 1 yearRue Tir de Ronet(FW) 31, 5020 Namur, BelgiumKBO/BCE: BE 1029.255.122
Summary

LDMO has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,075 and a net result of €25,575. Its solvency ranks better than 43% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 16-10-2025 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.380.381.483 5020 Namur, since 16-10-2025
Financial year end
31 December
Peppol
Reachable since 19-12-2025

Board and ownership

Board

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€36,107
Turnover
≈ €110,000
estimated
Profit
€25,575
Equity
€29,075
Total assets
€53,360
Score breakdownraises riskFounded in 2025lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 13-07-2026)Size: total assets €53,360Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 45% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 79
equity 54.5% of total assets
Liquidity 42
short-term debt 42.7% · cash 10.2%
Profitability 100
return on assets 47.9%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.8, above the usual 1.5. Short-term debt is 42.7% and cash 10.2% of total assets. 45.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 44% of them on solvency, 11% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Figures for financial year 2025 (filed on 13-07-2026)
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: total assets €53,360
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
18 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Recent changes

  1. · Gazette deed IncorporationStarting capital €3,500 · Appointment: Louis DAL MASO (director)
All 2 events

Comparable companies

These companies have the same main activity as LDMO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €45,100 and €63,500, founded in 2025.

CompanyTotal assetsGross margin
LDMO Namur€53,360€36,107
MELAPRONYL Zaventem€48,826€34,285
MaxUrgSi Sombreffe€63,538€34,920
Dr. Vandeputte, Anesthesie Destelbergen€48,044€41,635
DOCTEUR BILIUTA ALINA Liège€45,863€37,759
REVALEX Sint-Truiden€45,143€31,521
DOH Consulting Aalter€59,585€43,235
Full comparison

Key facts about LDMO

What is the company number of LDMO?
The company number of LDMO is 1029.255.122. The VAT number is the same number with BE in front: BE 1029.255.122.
Where is LDMO based?
The registered office is at Rue Tir de Ronet(FW) 31, 5020 Namur.Company details
What does LDMO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of LDMO?
The legal form of LDMO is Private limited company (BV).
When was LDMO founded?
LDMO was founded on 16-10-2025.
Is LDMO still active?
Yes, LDMO is an active enterprise in the KBO register.
What is the turnover of LDMO?
The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €36,107 and 47 comparable companies (NACE 86). It probably lies between €80,000 and €160,000.Financials
Is LDMO profitable?
In financial year 2025, LDMO made a profit of €25,575.
Where can I find the annual accounts of LDMO?
LDMO filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.